Literature DB >> 17163579

Effects of herbal medicinal products and food supplements on induction of CYP1A2, CYP3A4 and MDR1 in the human colon carcinoma cell line LS180.

Helena Brandin1, Eila Viitanen, Olle Myrberg, Ann-Kristin Arvidsson.   

Abstract

A selection of popular herbal medicinal products and food supplements were analysed for their potential to modulate the expression of the cytochrome P450 enzymes CYP1A2 and CYP3A4 and the transporter protein MDR1. A total of 31 products were analysed. Nine of the products have been approved by the Medical Products Agency (MPA) in Sweden and are marketed as herbal medicinal products. Twenty-two of the products have not been assessed by the MPA and are marketed as food supplements. LS180 cells were exposed to extracts from the different herbal products and real-time quantitative polymerase chain reaction, RT-QPCR, was subsequently used to analyse the relative mRNA levels of CYP1A2, CYP3A4 or MDR1 in treated and non-treated cells. Our results show that 17 of 31 products tested induced a two-fold expression or more for at least one of the genes analysed. Four products, of which a ginger-supplement was the most potent, induced all three genes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17163579     DOI: 10.1002/ptr.2057

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  10 in total

1.  Characterization of an Alginate Encapsulated LS180 Spheroid Model for Anti-colorectal Cancer Compound Screening.

Authors:  Tanya Smit; Carlemi Calitz; Clarissa Willers; Hanna Svitina; Josias Hamman; Stephen J Fey; Chrisna Gouws; Krzysztof Wrzesinski
Journal:  ACS Med Chem Lett       Date:  2020-04-03       Impact factor: 4.345

2.  Effects of adrenolytic mitotane on drug elimination pathways assessed in vitro.

Authors:  Dirk Theile; Walter Emil Haefeli; Johanna Weiss
Journal:  Endocrine       Date:  2014-12-27       Impact factor: 3.633

3.  Tissue distribution, gender-divergent expression, ontogeny, and chemical induction of multidrug resistance transporter genes (Mdr1a, Mdr1b, Mdr2) in mice.

Authors:  Yue Julia Cui; Xingguo Cheng; Yi Miao Weaver; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2008-10-14       Impact factor: 3.922

4.  Associations of herbal and specialty supplements with lung and colorectal cancer risk in the VITamins and Lifestyle study.

Authors:  Jessie A Satia; Alyson Littman; Christopher G Slatore; Joseph A Galanko; Emily White
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05       Impact factor: 4.254

Review 5.  A systematic review of anticancer effects of radix astragali.

Authors:  Yeehong Jung; Uimin Jerng; Sookyung Lee
Journal:  Chin J Integr Med       Date:  2015-12-07       Impact factor: 1.978

6.  A Systematic Review of Drug Metabolism Studies of Plants With Anticancer Properties: Approaches Applied and Limitations.

Authors:  Artitaya Thiengsusuk; Kanyarat Boonprasert; Kesara Na-Bangchang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2020-04       Impact factor: 2.441

7.  Estimation of the binding modes with important human cytochrome P450 enzymes, drug interaction potential, pharmacokinetics, and hepatotoxicity of ginger components using molecular docking, computational, and pharmacokinetic modeling studies.

Authors:  Jia-Xuan Qiu; Zhi-Wei Zhou; Zhi-Xu He; Xueji Zhang; Shu-Feng Zhou; Shengrong Zhu
Journal:  Drug Des Devel Ther       Date:  2015-02-16       Impact factor: 4.162

8.  Interaction potential of the multitargeted receptor tyrosine kinase inhibitor dovitinib with drug transporters and drug metabolising enzymes assessed in vitro.

Authors:  Johanna Weiss; Dirk Theile; Zdenek Dvorak; Walter Emil Haefeli
Journal:  Pharmaceutics       Date:  2014-12-16       Impact factor: 6.321

9.  Venetoclax (ABT-199) Might Act as a Perpetrator in Pharmacokinetic Drug-Drug Interactions.

Authors:  Johanna Weiss; Thomas Gajek; Bruno Christian Köhler; Walter Emil Haefeli
Journal:  Pharmaceutics       Date:  2016-02-24       Impact factor: 6.321

10.  Time-Resolved Effect of Interferon-Alpha 2a on Activities of Nuclear Factor Kappa B, Pregnane X Receptor and on Drug Disposition Genes.

Authors:  Dirk Theile; Lelia Wagner; Cindy Bay; Walter Emil Haefeli; Johanna Weiss
Journal:  Pharmaceutics       Date:  2021-05-28       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.